Maarten W. Van Den Berge

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 348 publications

Tozorakimab to Prevent COPD Exacerbations.

Tozorakimab to Prevent COPD Exacerbations.

Journal: The New England journal of medicine

Published: September 08, 2026

DNA methylation as a driver of lung fibroblast senescence in COPD.

DNA methylation as a driver of lung fibroblast senescence in COPD.

Journal: American journal of physiology. Lung cellular and molecular physiology

Published: July 08, 2026

Small Airways Disease predicts exacerbation risk in well-controlled, but not in poorly-controlled asthma: a post-hoc analysis of the ATLANTIS study.

Small Airways Disease predicts exacerbation risk in well-controlled, but not in poorly-controlled asthma: a post-hoc analysis of the ATLANTIS study.

Journal: The journal of allergy and clinical immunology. In practice

Published: May 08, 2026

Fibroblast cross talk promotes mucin synthesis by COPD-derived airway epithelial cells.

Fibroblast cross talk promotes mucin synthesis by COPD-derived airway epithelial cells.

Journal: American journal of physiology. Lung cellular and molecular physiology

Published: April 09, 2026

Genome-wide association study of asthma with high treatment burden and/or worse outcomes defined using electronic healthcare data in UK Biobank.

Genome-wide association study of asthma with high treatment burden and/or worse outcomes defined using electronic healthcare data in UK Biobank.

Journal: ERJ open research

Published: February 27, 2026

Phase III LUNA clinical programme: design of four randomised, double-blind, placebo-controlled studies assessing the efficacy and safety of tozorakimab in patients with symptomatic COPD and a high risk of exacerbations.

Phase III LUNA clinical programme: design of four randomised, double-blind, placebo-controlled studies assessing the efficacy and safety of tozorakimab in patients with symptomatic COPD and a high risk of exacerbations.

Journal: BMJ open respiratory research

Published: February 23, 2026

Publisher Correction: Interpretable inflammation landscape of circulating immune cells.

Publisher Correction: Interpretable inflammation landscape of circulating immune cells.

Journal: Nature medicine

Published: January 26, 2026

Genetic variants underpinning lung function decline in the Lifelines general population cohort study.

Genetic variants underpinning lung function decline in the Lifelines general population cohort study.

Journal: ERJ open research

Published: December 16, 2025

Genetic Variants at Immunoglobulin and Mitochondrial Loci Associated with Chronic Hypercapnia in COPD.

Genetic Variants at Immunoglobulin and Mitochondrial Loci Associated with Chronic Hypercapnia in COPD.

Journal: American journal of respiratory cell and molecular biology

Published: December 12, 2025

Clinical phenotyping of asthma patients with elevated sputum eosinophils and low blood eosinophils: a post-hoc analysis of the multicentre ATLANTIS cohort.

Clinical phenotyping of asthma patients with elevated sputum eosinophils and low blood eosinophils: a post-hoc analysis of the multicentre ATLANTIS cohort.

Journal: EBioMedicine

Published: November 28, 2025

Lung fibroblast activation protein expression is associated with extracellular matrix remodelling in post-acute sequelae of SARS-CoV-2.

Lung fibroblast activation protein expression is associated with extracellular matrix remodelling in post-acute sequelae of SARS-CoV-2.

Journal: ERJ open research

Published: November 06, 2025

Identification of distinct gene and miRNA expression profiles in severe early-onset COPD providing novel insights in disease pathogenesis.

Identification of distinct gene and miRNA expression profiles in severe early-onset COPD providing novel insights in disease pathogenesis.

Journal: Thorax

Published: October 28, 2025

Showing 1-12 of 348

Last Updated: 09/26/2026